Universal antimicrobial resistance detection from clinical bacterial isolates using proteomics

ABSTRACT: Antimicrobial resistance (AMR) is an increasing challenge for therapy and management of bacterial infections. Currently, antimicrobial resistance detection relies on phenotypic assays, which are performed independently of species identification. On the contrary, phenotypic prediction from molecular data using genomics is gaining interest in clinical microbiology and might become a serious alternative in the future. Although, in general protein analysis should be superior to genomics for phenotypic prediction, no untargeted proteomics workflow specifically related to AMR detection has been proposed so far. In this study, we present a universal proteomics workflow to detect the bacterial species and antimicrobial resistance related proteins in the absence of secondary antibiotic cultivation in less than 4 h from a primary culture. The method was validated using a sample cohort of 7 bacterial species and 11 AMR determinants represented by 13 protein isoforms which resulted in a sensitivity of 92 % (100 % with vancomycin inference) and a specificity of 100 % with respect to AMR determinants. This proof-of concept study demonstrates the high potential of untargeted proteomics for clinical microbiology.

INSTRUMENT(S):

ORGANISM(S): Salmonella Enterica Subsp. Enterica Serovar Typhimurium Salmonella Enterica Subsp. Enterica Serovar Infantis Escherichia Coli Enterobacter Cloacae Subsp. Cloacae Enterococcus Faecium Citrobacter Freundii Klebsiella Pneumoniae Subsp. Pneumoniae

SUBMITTER: Christian Blumenscheitc  

LAB HEAD: Robert Koch-Institute

PROVIDER: PXD022425 | Pride | 2021-11-25

REPOSITORIES: Pride